Five things for pharma marketers to know: Wednesday, July 8, 2020
Novavax receives $1.6b for COVID-19 vaccine; Trump begins process of withdrawal from WHO; PPE shortages return as cases spike.
COVID-19
Five things for pharma marketers to know: Tuesday, July 7, 2020
Doctors urge WHO to acknowledge airborne transmission of COVID-19; FDA approves Becton Dickinson’s rapid antigen test; Webcast: Leverage machine learning, AI to improve trial recruitment.
Excerpt: Health media in the COVID-19 era
Dr. Judith Simmons talks social media follows, voices from the frontlines and coverage blind spots.
Arthur Sadoun warns of ‘very tough days’ ahead as Publicis fights to return to growth
He delivered last Sunday message to Publicis staff.
Coronavirus Briefing: Reopening goes awry, Remdesivir’s price tag and the point-of-care pivot
This week’s Haymarket Media Coronavirus Briefing is 1,388 words and will take you seven minutes to read.
Gilead names remdesivir price
The treatment will cost $3,120 for a five-day treatment course for a patient with private insurance in the U.S.
Point of care and the pandemic
The inside story of how one of healthcare marketing’s most important channels navigated COVID-19 – and may have emerged stronger and smarter.
Cannes Lions Live: Marketing in a time of racial justice and a pandemic
Leaders discussed how agencies can evolve in light of the movement for racial justice and the COVID-19 pandemic.
Cannes Lions Live: Health, activism and equality in advertising
Advertising leaders discussed COVID-19, Black Lives Matter and gender equality at the Cannes Lions Live virtual event.
Publicis Health revamps internship program into virtual summer academy in light of pandemic
The virtual academy allowed Publicis Health to bring in more students from different parts of the country and world.
